Hypertension is the most frequent medical complication of pregnancy, occurring in 10% of pregnancies and being the main cause of perinatal mortality and morbidity (1-3). The hypertensive processes in pregnancy are classified as preeclampsia (PE), transient hypertension (TH), and chronic hypertension (CH) and super-imposed preeclampsia (4).
transient hypertension and preeclampsia (8) (9) (10) (11) (12) . Elevated maternal CRP levels are shown in all preeclampsias (13, 14) . However, no study has considered CRP levels in differential form of hypertensive disorders and its correlations with fetus neonatal outcome.
Even in this contest, the differential diagnosis of hypertensive disorders induced by pregnancy is important because some patients could be subjected to more intensive antenatal cares and possibly anti-inflammatory therapy.
The study endpoints were:
• To assess the role of CRP as marker for differential diagnosis in hypertensive disorders of pregnancy.
• To assess whether CRP increase is associated with preeclampsia and HELLP syndrome and with negative obstetric outcomes such as premature delivery and low birth weight.
PATIENTS AND METHODS
Between January 2000 and October 2003, in a prospective cross-sectional study, a total of 322 pregnant women at 24 to 32 weeks' gestation were enrolled. All pregnant women of this study signed a written informed consensus to investigate the possible use of CRP as a marker. The study was approved by the ethical committee of the medical school and was conducted at the Obstetric-Gynecology Hospital in Padua (Italy).
At the time of sampling, 190 women had normal singleton pregnancies with fetuses of appropriate size for date. We considered 190 mothers apparently without medical problems, no medications, and negative cervical smear results as the control group (group A). Sixty-three women had preeclampsia (group B), 31 women presented with transient hypertension (group C), 19 had HELLP syndrome (group D), and 19 had CH (group E). All these diseases were defined according to the American College of Obstetricians and Gynecologists' diagnostic criteria (4) . Gestational age at screening, maternal age, body mass index (BMI), ethnic group, and parity were recorded at study entrance.
Blood Sampling and CRP Measurements
The blood samples were drawn from the study participants for CRP analysis and other hematologic and urinary parameters (platelet, antithrombin-3 [AT], fibronectin [FN] , and proteinuria 24-hour analysis). CRP was measured with a highly sensitive method by immunonephelometric assay. The polystyrene particles sensitized with monoclonal anti-CRP Ig are agglutinated while mixing with samples containing the CRP to be measured. The intensity of the light dispersed by the nephelometer is determined by the CRP content of the sample.
Platelets, AT, and 24-hour proteinuria were measured by means of automatic counters. Plasma fibronectin was measured by nephelometry using biochemical kits; values between 250 and 400 ng/L were considered normal.
Defining Clinical Outcome
Preeclampsia was defined according to the criteria of the American College Obstetric Gynecology (4) . Under this classification, hypertension is defined as one diastolic blood pressure reading greater than 140 mmHg or two consecutive diastolic blood pressure readings greater than 90 mmHg at least 4 hours apart. Significant proteinuria is defined as greater than 300 mg total protein in a 24-hour urine collection or 1+ proteinuria by stick .
Using this classification, preeclampsia was defined as hypertension in combination with proteinuria developing after 20 weeks in a group of previously normotensive women.
Transient hypertension (TH) was defined as a syndrome that can appear during the second trimester (4) .
Chronic hypertension (CH) was defined as a blood pressure greater than 140/90 mmHg before pregnancy or diagnosed before 20 gestational weeks and persisting 12 gestational weeks after delivery (4) . HELLP syndrome (HS) was defined as a syndrome characterized by hemolysis, elevated liver enzymes, and low platelets (15) . Intrauterine growth restriction (IUGR) was defined by a birth weight below the fifth percentile for gestation and gender of the neonate (16) .
Statistical Analysis
Statistical analysis was performed using an SPSS (Statistical Package for the Social Sciences) version 11.0 software package (SPSS, Chicago, USA). The Wilk-Shapiro test was used to check the normality of distribution of the main variables. The Fisher exact test was used to compare categorical variables and the Mann-Whitney test and Student paired t test was used when appropriate to compare continuous variables. The Pearson correlation test was used to evaluate and quantify association between variables.
RESULTS
The demographic and clinical characteristics of women according to the outcome of pregnancy are given in Table 1 . There was no difference in race, parity, and weeks' gestation at sampling: BMI was significantly higher in TH than the other groups. The statistical differences among the blood pressure and hematologic parameters are shown in Table 1 .
The mean serum CRP concentration was 7.1±7.9 mg/L (median 3.5 mg/L; interquartile range: 3.1-7.6 mg/L). There was no CRP statistically significant difference between the control group and the chronic hypertension group (p=0.22).
CRP serum concentrations were significantly higher in groups B, C, and D in comparison with the normal control group (group A) (p=0.005). The highest CRP serum levels were observed in women who developed HELLP syndrome. In the whole population systolic and diastolic pressure value inversely correlated with weight at deliv-ery (p=0,0001) ( Fig. 1 ). Systolic and diastolic pressure values inversely correlate with weeks of gestation at delivery (p=0,0001) ( Fig. 2) . CPR levels in patients with preeclampsia and HS inversely correlate with birth weight (p=0,0001) ( Fig. 3 ) and gestational weeks at delivery (p=0.001) ( Fig. 4 ).
In the whole study population, a multiple logistic regression analysis showed that CRP and diastolic blood pressure values were the only variables with a significant negative correlation with low birth weight and preterm birth (CRP: p=0.0097; diastolic blood pressure p=0.02) with odds ratio of 1.12 (95% CI: 1.02-1.24) for CRP and 1.07 (95% CI 1.01-1.14) for diastolic blood pressure, respectively. Furthermore, CRP plasma levels were also predictive for a birth weight (i.e., <2,500 g) outcome: in comparison with women in the first quartile range of CRP (i.e., CRP levels less than 3.1 mg/dL) the relative risk of low birth weight in the second and third quartile (i.e., CRP levels = 3.2-7.6 mg/dL) was 2.2 (95% CI: 0.4-2.4) and 7.9 (95% CI: 5.6-8.9) in the higher quartile (i.e., CRP levels greater than 7.6 mg/dL). CRP levels have no correlation with coagulation parameters (AT, platelets), renal involvement (proteinuria), and plasma fibronectin levels.
DISCUSSION
In pregnancy, CRP has been studied primarily as a potential early marker for chorioamnionitis in women with premature rupture of membranes and as a predictor of outcomes in preterm labor, including the likelihood of successful tocolysis (17) .
Additional studies have attempted to define normal reference ranges for CRP at various stages of normal gestation, delivery , and puerperium (18) .
In previous studies, excluding PE, CPR has not been examined in detail in other hypertensive pregnancy disorders, including TH , HS, and CH (13, 14) . About the first endpoint, this study provides evidence that CRP levels were higher in PE, HS, and TH than in the control and the CH groups.
Normal plasma levels of CRP may be an important marker of differential diagnosis between TH and CH.
The differential diagnosis of chronic hypertension may be very difficult if not anamnestic factors (previously known essential hypertension, renal disease or other secondary causes of hypertension) are available. However, at first presentation, it is often difficult to know if a pregnant woman with new hypertension after 20 weeks of gestation will remain TH. Alternatively she may develop PE or she may be diagnosed with CH.
The patients with preexisting hypertension may be treated only with antihypertensive therapy. Generally the result is a good maternal and fetal outcome in accordance with our findings.
The previous study has demonstrated that early onset TH (less than 32 weeks' gestation) occurred in PE in 42% of all cases, independent of antihypertensive therapy (19) . This was independent of whether or not anti-hypertensive therapy had been given. This group should be kept under close observation.
In TH, PE, and HS, CRP levels were higher than those in the control and CH groups, suggesting that inflammation may be the common pahogenetic cause of TH and PE.
Inflammation has been shown to correlate with endothelial dysfunction and related with renin-angiotensin system (20) . As a result, it has been hypothesized that hypertension may be in part an inflammatory disorder. Higher levels of CRP may increase blood pressure by reducing nitric oxide production in endothelial cells, causing vasoconstriction and increasing endothelin-1 production. These data provide evidence that inflammation may be an important mechanism through which hypertension develops (20) .
As emphasized in our work, CRP levels correlated with systolic and diastolic BP, whereas they do not correlate with fibronectin levels and any organ damage markers, such as renal and hepatic coagulation function. In this study, FN levels are not correlated with fetal weight at birth and to weeks' gestation at delivery.
About the second endpoint, in our study CRP levels in preeclampsia are believed to correlate with preeclamptic process severity, preterm delivery, and poor neonatal outcome. In patients with HS and PE, the CRP mean is higher than in any other group; weeks of gestation at delivery and birth weight at delivery were shown to be statistically lower. We hypothesize that fetusneonatal outcome is due both to increased levels of CRP and to the different origin of hypertensive disorder of pregnancy. In early onset PE, it is believed that the maternal syndrome may be somehow caused by oxidative stress in the placenta associated with spiral arteries disease. Because preeclampsia is characterized by an intense inflammatory response, CRP levels increase proportionally with increasing levels of cytokines; these cytokines seem to play an important role in causing endothelial damage (6, 7) . In this case, a placental factor is secreted in response to placental ischemia induced by incomplete trophoblastic invasion and uterine artery remodeling may be toxic for endothelial cells. (5) .
In fact, as demonstrated in our finding, patients with PE and HS with BMI less than 25, are characterized by an intense acute inflammatory response with higher CRP levels, and poor fetus neonatal outcome with early preterm labor. In contrast, in our study, the TH with elevated BMI, seems to produce a good fetus neonatal outcome.
In this case, subclinical systemic inflammation, marked by a moderate increase in levels of CRP, could derive from maternal adipose tissue, without immediate placental damage. Elevated BP is correlated with an increase of adipose cells (9, (21) (22) (23) . Furthermore, epidemiological studies designed specifically to test the association between BMI and CRP have shown a gradual increase in CRP with BMI increase (9) . There is evidence that CRP might be the intermediary in pathways between BMI and hypertension.
Adipose cells are the major source of basal IL-6 and TNFα secretion, which are the principal determinants of hepatic CRP protein production (22) . Obesity may act through its association with insulin resistance, a syndrome of metabolic derangement characterized by hyperinsulinemia, hyperlipidemia, hypertension, and endothelial dysfunction (23) . Consequently, we conclude that the hypothesis that inflammation contributes to the pathogenesis of hypertension is more plausible. In these forms characterized by a higher BMI, the prevention of hypertension is essentially based on diet control. In contrast in early onset PE with low BMI the pathogenesis is linked to an altered placentation and there is no possibility of prevention. Considering the flogistic pathogenesis, we suppose that an anti-inflammatory therapy could function better because it is pathogenic and not symptomatic.
So far, preeclamptic therapy has consisted of only symptomatic treatment capable of controlling hypertension, such as plasma expanders and albumin. Indeed within a few days, all patients underwent cesarean section (24) . High-dose AT therapy was recently found to prolong pregnancy, exerting a protective anti-inflammatory effect against endothelial damage (25, 26) . In addition, in HS patients receiving corticosteroids, the time of recovery was shorter and maternal mobility was significantly reduced; moreover, no hemorrhagic complications were observed and the patients presenting with DIC at the time of admission showed a significant improvement in the postpartum period (27) .
Although the mechanism by which corticosteroids exert a beneficial effect on the regression of HELPP syndrome remained unclear until quite recently, on the basis of our findings, it seems due to anti-inflammatory effect of corticosteroid therapy (27, 28) . In this respect, CRP levels may be clinically useful to monitor disease activity response to antiflogistic treatment in early onset preeclampsia patients. In these cases, expectant management in highly specialized units with the necessary maternal and fetal surveillance can result in improvement of fetal survival and prevention of maternal complications (29) . Therefore, future and perspective studies involving a larger number of patients are expected to confirm what we found, assessing that with this type of therapy and treatment, it is possible to extend pregnancy.
